Status:

TERMINATED

A Study of Belcesiran in Patients With AATLD

Lead Sponsor:

Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Conditions:

Alpha 1-Antitrypsin Deficiency

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

This is a multiple dose, randomized, placebo-controlled, double-blind study of belcesiran to evaluate the safety, tolerability, PK, and PD in adult patients with PiZZ AATD-associated liver disease (AA...

Detailed Description

AATD-associated liver disease is a progressive condition resulting in liver fibrosis, cirrhosis, and in some cases hepatocellular carcinoma. The lack of functional alpha-1 antitrypsin (AAT) in individ...

Eligibility Criteria

Inclusion

  • 18 to 75 years, inclusive, at the time of consent.
  • Documented diagnosis of PiZZ-type alpha-1 antitrypsin deficiency, confirmed by genotyping. Historical genotyping data may be used, if available.
  • AATD-associated liver disease documented by liver biopsy at Screening.
  • Consent to undergo paired liver biopsies.
  • Lung, renal and liver function within acceptable limits
  • Capable of giving signed informed consent, which includes compliance with the requirements and restrictions listed in the ICF and in this protocol.

Exclusion

  • History of chronic liver disease other than non-alcoholic fatty liver disease from any cause other than PiZZ-type alpha-1 antitrypsin deficiency.
  • Child-Pugh Score B or C.
  • History of one single severe exacerbation of underlying lung disease in the year prior to randomization.
  • History of clinically significant respiratory infections (including pneumonia and lower respiratory tract infections), as determined by the Investigator, in the 3 months prior to screening
  • Use of an RNAi drug at any time.

Key Trial Info

Start Date :

February 12 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 29 2024

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT04764448

Start Date

February 12 2021

End Date

May 29 2024

Last Update

December 31 2024

Active Locations (23)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (23 locations)

1

University of California - San Diego

La Jolla, California, United States, 92093

2

University of Florida

Gainesville, Florida, United States, 32611

3

Medical University of South Carolina

Charleston, South Carolina, United States, 29425

4

St Vincent's Hospital Melbourne

Melbourne, Australia